Soleno Therapeutics, Inc. · NASDAQ:SLNO
Vivo Opportunity Fund Holdings, L.P. reported a 7.40% stake in Soleno Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 12, 2025
Vivo Opportunity Fund Holdings, L.P. reported a 7.40% stake in Soleno Therapeutics, Inc., 3,958,294 shares, as a passive investor on Jun 30, 2025. Filed Aug 12, 2025 (Schedule 13G/A).
- Stake
- 7.40%
- Shares
- 3,958,294
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 7.40% | 3,958,294 |
| Vivo Opportunity, LLC | 7.40% | 3,958,294 |
Source
Related
- Soleno Therapeutics, Inc.
- Vivo Opportunity, LLC
- Soleno Therapeutics, Inc. shareholders
- Schedule 13G/A · Vivo Opportunity, LLC · Nov 14, 2025
- Schedule 13G/A · Vivo Opportunity, LLC · Mar 31, 2025
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Form 4 · Yen Kristen · May 18, 2026
- Form 4 · Volck Birgitte · May 18, 2026
- Form 4 · Sinclair Andrew · May 18, 2026
- Form 4 · Pauls Matthew · May 18, 2026